An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT05315713 · TERMINATED
Trial details
- NCT number
- NCT05315713
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2023-07-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.